Qube Research & Technologies (QRT)’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$24M Sell
853,600
-472,200
-36% -$12.6M 0.03% 782
2025
Q4
$33M Sell
1,325,800
-533,000
-29% -$13.4M 0.03% 674
2025
Q3
$47.4M Sell
1,858,800
-2,774,800
-60% -$68.5M 0.05% 483
2025
Q2
$112M Sell
4,633,600
-136,600
-3% -$3.19M 0.11% 224
2025
Q1
$121M Buy
4,770,200
+2,768,400
+138% +$72.4M 0.14% 180
2024
Q4
$53.1M Sell
2,001,800
-1,314,400
-40% -$35.7M 0.07% 359
2024
Q3
$96M Buy
3,316,200
+2,396,000
+260% +$69.9M 0.14% 159
2024
Q2
$25.7M Sell
920,200
-2,890,400
-76% -$79.6M 0.04% 522
2024
Q1
$106M Buy
3,810,600
+1,861,000
+95% +$51.6M 0.17% 144
2023
Q4
$56.1M Buy
1,949,600
+1,348,300
+224% +$40.8M 0.11% 236
2023
Q3
$19.9M Buy
601,300
+301,300
+100% +$10.7M 0.05% 413
2023
Q2
$11M Buy
+300,000
New +$11.7M 0.04% 513
2023
Q1
Sell
-350,000
Closed -$17.9M 2905
2022
Q4
$17.9M Buy
+350,000
New +$16.8M 0.1% 308

Other funds holding PFE

Qube Research & Technologies (QRT)'s PFE Position: Q4 2025 in Review

Qube Research & Technologies (QRT) sold out of Pfizer (PFE) in Q4 2025, closing a stake of 160,523 shares — an estimated $4.05M sold.

Qube Research & Technologies (QRT) first reported a position in PFE in Q1 2018 and held it in 25 quarters. The position peaked at $271M in Q1 2025. 2,905 funds tracked by Wall St. Rank hold PFE as of Q4 2025.

  • Qube Research & Technologies (QRT) reported no remaining Pfizer position as of Q4 2025 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 160,523 Pfizer shares in Q4 2025, an estimated $4.05M.
  • Qube Research & Technologies (QRT) first reported a position in Pfizer in Q1 2018 and held it in 25 quarters.
  • Qube Research & Technologies (QRT)'s Pfizer position peaked at $271M in Q1 2025.
  • 2,905 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q4 2025, filed 17 Feb 2026.